Werbung
Werbung

ELVN

ELVN logo

Enliven Therapeutics, Inc. Common Stock

42.40
USD
Gesponsert
-0.58
-1.35%
29. Apr., 15:59 UTC -4
Geschlossen
exchange

Vor-Markt

42.26

-0.14
-0.34%

Enliven Therapeutics, Inc. Common Stock Finanzieller Schnappschuss

Markt Cap
2.57B
Beta
0.26
Gewinn pro Aktie (EPS)
-1.86
Kurs-Buchwert-Verhältnis (P/B)
5.89
Operative Marge
--
Gesamtverschuldung/Eigenkapital (D/E)
0.00%
Kurs-Gewinn-Verhältnis
--
Eigenkapitalrendite (ROE)
-24.22%
Aktuelles Verhältnis
28.66%
Freier Cash Flow
-70.25M
ELVN Profil

Ertragsdiagramm

ELVNVerdienste

Aktien im Trend

Arcellx, Inc. Common Stock logo
Arcellx, Inc. Common Stock$115.07
0.00%
Meta Platforms, Inc. Class A Common Stock logo
Meta Platforms, Inc. Class A Common Stock$669.12
-0.33%
Ascendis Pharma A/S Ordinary Share logo
Ascendis Pharma A/S Ordinary Share$220.28
-0.81%
Intel Corp logo
Intel Corp$94.75
+12.10%
Evercore Inc. logo
Evercore Inc.$324.14
-4.81%
Corebridge Financial, Inc. logo
Corebridge Financial, Inc.$26.95
+0.07%
Nvidia Corp logo
Nvidia Corp$209.25
-1.84%
Werbung